247 related articles for article (PubMed ID: 11435472)
21. Nf1-/- Schwann cell-conditioned medium modulates mast cell degranulation by c-Kit-mediated hyperactivation of phosphatidylinositol 3-kinase.
Chen S; Burgin S; McDaniel A; Li X; Yuan J; Chen M; Khalaf W; Clapp DW; Yang FC
Am J Pathol; 2010 Dec; 177(6):3125-32. PubMed ID: 21037083
[TBL] [Abstract][Full Text] [Related]
22. p21ras initiates Rac-1 but not phosphatidyl inositol 3 kinase/PKB, mediated signaling pathways in T lymphocytes.
Genot E; Reif K; Beach S; Kramer I; Cantrell D
Oncogene; 1998 Oct; 17(13):1731-8. PubMed ID: 9796702
[TBL] [Abstract][Full Text] [Related]
23. SWAP-70 regulates c-kit-induced mast cell activation, cell-cell adhesion, and migration.
Sivalenka RR; Jessberger R
Mol Cell Biol; 2004 Dec; 24(23):10277-88. PubMed ID: 15542837
[TBL] [Abstract][Full Text] [Related]
24. A novel potential effector of M-Ras and p21 Ras negatively regulates p21 Ras-mediated gene induction and cell growth.
Ehrhardt GR; Korherr C; Wieler JS; Knaus M; Schrader JW
Oncogene; 2001 Jan; 20(2):188-97. PubMed ID: 11313946
[TBL] [Abstract][Full Text] [Related]
25. Concomitant activation of the PI3K-Akt and the Ras-ERK signaling pathways is essential for transformation by the V-SEA tyrosine kinase oncogene.
Agazie Y; Ischenko I; Hayman M
Oncogene; 2002 Jan; 21(5):697-707. PubMed ID: 11850798
[TBL] [Abstract][Full Text] [Related]
26. Signals from the Ras, Rac, and Rho GTPases converge on the Pak protein kinase in Rat-1 fibroblasts.
Tang Y; Yu J; Field J
Mol Cell Biol; 1999 Mar; 19(3):1881-91. PubMed ID: 10022875
[TBL] [Abstract][Full Text] [Related]
27. Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.
Yang FC; Chen S; Clegg T; Li X; Morgan T; Estwick SA; Yuan J; Khalaf W; Burgin S; Travers J; Parada LF; Ingram DA; Clapp DW
Hum Mol Genet; 2006 Aug; 15(16):2421-37. PubMed ID: 16835260
[TBL] [Abstract][Full Text] [Related]
28. Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.
Jeay S; Pianetti S; Kagan HM; Sonenshein GE
Mol Cell Biol; 2003 Apr; 23(7):2251-63. PubMed ID: 12640111
[TBL] [Abstract][Full Text] [Related]
29. Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins.
Frost JA; Steen H; Shapiro P; Lewis T; Ahn N; Shaw PE; Cobb MH
EMBO J; 1997 Nov; 16(21):6426-38. PubMed ID: 9351825
[TBL] [Abstract][Full Text] [Related]
30. Phosphoinositide 3-kinase induces scattering and tubulogenesis in epithelial cells through a novel pathway.
Khwaja A; Lehmann K; Marte BM; Downward J
J Biol Chem; 1998 Jul; 273(30):18793-801. PubMed ID: 9668053
[TBL] [Abstract][Full Text] [Related]
31. Signaling through mitogen-activated protein kinase and Rac/Rho does not duplicate the effects of activated Ras on skeletal myogenesis.
Ramocki MB; Johnson SE; White MA; Ashendel CL; Konieczny SF; Taparowsky EJ
Mol Cell Biol; 1997 Jul; 17(7):3547-55. PubMed ID: 9199290
[TBL] [Abstract][Full Text] [Related]
32. Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation signalling pathways.
Lim L; Manser E; Leung T; Hall C
Eur J Biochem; 1996 Dec; 242(2):171-85. PubMed ID: 8973630
[TBL] [Abstract][Full Text] [Related]
33. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation.
King WG; Mattaliano MD; Chan TO; Tsichlis PN; Brugge JS
Mol Cell Biol; 1997 Aug; 17(8):4406-18. PubMed ID: 9234699
[TBL] [Abstract][Full Text] [Related]
34. Rac is activated by tumor necrosis factor alpha and is involved in activation of Erk.
Nosaka Y; Arai A; Kanda E; Akasaki T; Sumimoto H; Miyasaka N; Miura O
Biochem Biophys Res Commun; 2001 Jul; 285(3):675-9. PubMed ID: 11453646
[TBL] [Abstract][Full Text] [Related]
35. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism.
Romerio F; Riva A; Zella D
Br J Cancer; 2000 Aug; 83(4):532-8. PubMed ID: 10945503
[TBL] [Abstract][Full Text] [Related]
36. Distinct Roles of Small GTPases Rac1 and Rac2 in Histamine H
Kuramasu A; Wakabayashi M; Inui M; Yanai K
J Pharmacol Exp Ther; 2018 Oct; 367(1):9-19. PubMed ID: 30021868
[TBL] [Abstract][Full Text] [Related]
37. Regulation of Raf by Akt controls growth and differentiation in vascular smooth muscle cells.
Reusch HP; Zimmermann S; Schaefer M; Paul M; Moelling K
J Biol Chem; 2001 Sep; 276(36):33630-7. PubMed ID: 11443134
[TBL] [Abstract][Full Text] [Related]
38. RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers.
Nichols RJ; Haderk F; Stahlhut C; Schulze CJ; Hemmati G; Wildes D; Tzitzilonis C; Mordec K; Marquez A; Romero J; Hsieh T; Zaman A; Olivas V; McCoach C; Blakely CM; Wang Z; Kiss G; Koltun ES; Gill AL; Singh M; Goldsmith MA; Smith JAM; Bivona TG
Nat Cell Biol; 2018 Sep; 20(9):1064-1073. PubMed ID: 30104724
[TBL] [Abstract][Full Text] [Related]
39. Kinase suppressor of Ras (KSR1) modulates multiple kit-ligand-dependent mast cell functions.
Chen M; Burgin S; Staser K; He Y; Li X; Robinson M; Jiang L; Chan RJ; Ingram D; Clapp DW
Exp Hematol; 2011 Oct; 39(10):969-76. PubMed ID: 21726514
[TBL] [Abstract][Full Text] [Related]
40. R-Ras3, a brain-specific Ras-related protein, activates Akt and promotes cell survival in PC12 cells.
Kimmelman AC; Osada M; Chan AM
Oncogene; 2000 Apr; 19(16):2014-22. PubMed ID: 10803462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]